Seattle Genetics Inc. (SGEN) is priced at $164.76 after the most recent trading session. At the very opening of the session, the stock price was $147.57 and reached a high price of $150.52, prior to closing the session it reached the value of $149.97. The stock touched a low price of $146.97.
Recently in News on September 14, 2020, Seattle Genetics and Merck Announce Two Strategic Oncology Collaborations. Companies to Co-Develop and Co-Commercialize Seattle Genetics’ Antibody-Drug Conjugate Ladiratuzumab Vedotin Globally; Merck to Acquire $1 Billion Equity Stake in Seattle Genetics Common Stock. You can read further details here
Seattle Genetics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $187.99 on 07/20/20, with the lowest value was $90.57 for the same time period, recorded on 03/16/20.
Seattle Genetics Inc. (SGEN) full year performance was 111.58%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Seattle Genetics Inc. shares are logging -12.35% during the 52-week period from high price, and 139.68% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $68.74 and $187.99.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1046083 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Seattle Genetics Inc. (SGEN) recorded performance in the market was 31.25%, having the revenues showcasing -0.79% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 25.39B, as it employees total of 1605 workers.
The Analysts eye on Seattle Genetics Inc. (SGEN)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 160.23, with a change in the price was noted +24.98. In a similar fashion, Seattle Genetics Inc. posted a movement of +17.97% for the period of last 100 days, recording 1,146,069 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SGEN is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Seattle Genetics Inc. (SGEN)
Raw Stochastic average of Seattle Genetics Inc. in the period of last 50 days is set at 45.95%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 85.74%. In the last 20 days, the company’s Stochastic %K was 43.93% and its Stochastic %D was recorded 28.44%.
Considering, the past performance of Seattle Genetics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 31.25%. Additionally, trading for the stock in the period of the last six months notably improved by 46.00%, alongside a boost of 111.58% for the period of the last 12 months. The shares increased approximately by 0.18% in the 7-day charts and went up by -5.55% in the period of the last 30 days. Common stock shares were lifted by -0.79% during last recorded quarter.